Energy tycoon Boone Pickens predicted Friday that oil prices would be back near $70 or $80 a barrel by the fourth quarter of this year.» Read More
Michael Morrissey, Exelixis president & CEO, provides insight on clinical research of prostate cancer and its cancer drug Cometriq.
"Shark Tank's" Daymond John discusses which participants are successful on "Shark Tank," and the current environment for selling some of these successful businesses.
CNBC's Julia Boorstin reports on 3 rising social startups, including "Jelly," which enables users to ask questions to their social network through pictures.
CNBC's Phil LeBeau speaks with Bentley Motors Chief Operating Officer Christophe Georges about the launch of the Continental GT V8.
What can retailers do to protect customers' data? HSN Inc. CEO Mindy Grossman discusses how her company has invested in data security.
HSN Inc. CEO Mindy Grossman says her company invested in mobile, and remained focused on proprietary product and value and the customer experience. "It's about generosity; what are you doing for your customer not just because you want to sell them something," she says.
Alexandria Real Estate Equities founder, chairman and CEO Joel Marcus discuss its firm's success, and how rising yields impact its dividend.
Alexandria Real Estate Equities founder, chairman and CEO Joel Marcus discuss real estate demand in the biotech industry.
CNBC's Brian Sullivan and Josh Lipton discuss venture capital investments in health care.
Perrigo CEO Joseph Papa discusses how its new headquarters in Ireland will impact its tax structure, and whether the company will add a dividend.
Perrigo CEO Joseph Papa provides insight on the current flu season, and how it plans on getting its name better known.
Biogen Idec CEO George Scangos discusses the busy year ahead for the company, including the EU launch of Tecfidera and when a dividend will be offered.
The outlook for biotech is "wonderful," explains Sam Isaly, Orbimed Advisors managing partner.
Agios CEO David Schenkein on a new approach to cancer, and the outlook for product approval, from the JPMorgan Health Care Conference in San Francisco.
Accuray CEO Joshua Levine talks to CNBC's Brian Sullivan about his company's history of innovation and how it deals with larger competitors.
Target disclosed that a mass information breach involved data belonging to up to 70 million customers.
Discussing current market action and what it signals about economic growth, with James Paulsen, Wells Capital Management CIO, and Linda Duessel, Federated Investors.
Digging into the financials of various retailers, including Five Below and Sears, with Jan Kniffen, CEO of Worldwide Enterprises, and Herb Greenberg of TheStreet.com.
Alnylam CEO John Maraganore talks to Brian Sullivan about today's big announcement of a huge investment in the company by Genzyme. From the JPM Health Care Conference in San Francisco.
Brian asks InterMune Chairman, President and CEO Dan Welch for an update on its drug Esbriet, and chances for U.S. approval.